Tom Rosenfeld
Analyst, Intron Health Research
Replay available
Vivoryon Therapeutics N.V. (0R3M) Q2 2026 Earnings Call
Vivoryon Therapeutics N.V. (LSE: 0R3M) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joseph Hedden
Analyst, RX Securities
Michael Schäfer
Chief Business Officer, Vivorion
Frank Lieber
Chief Executive Officer, Vivorion
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vivoryon Therapeutics N.v..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04159-c5bc-77a0-913f-1d1f05e177e7 Created: 2026-08-27T03:53:18.915Z Duration: 1781.969 Channels: 1 00:00:00.000 -- 00:00:02.000 Good morning or good afternoon, 00:00:02.080 -- 00:00:04.319 everyone, and thank you for joining us today 00:00:04.319 -- 00:00:05.600 for Vivoryon's 00:00:05.600 -- 00:00:08.320 first half twenty twenty six results call. 00:00:08.960 -- 00:00:11.679 Earlier today, we issued a press release reporting 00:00:11.679 -- 00:00:14.240 our first half twenty twenty six financial 00:00:14.240 -- 00:00:16.855 results and business update, which can be found 00:00:16.855 -- 00:00:20.535 on Vivoryon's website at www.vivariant.com. 00:00:21.975 -- 00:00:23.895 On the call with me today are Frank 00:00:23.895 -- 00:00:27.735 Weber, our Chief Executive Officer Markus Erstfeld, our 00:00:27.735 -- 00:00:29.015 Chief Financial Officer 00:00:29.369 -- 00:00:32.009 as well as Mikhail Schafer, our Chief Business 00:00:32.009 -- 00:00:32.729 Officer. 00:00:34.890 -- 00:00:36.969 Before we start, I would like to remind 00:00:36.969 -- 00:00:38.809 you that during this conference call, we will 00:00:38.809 -- 00:00:41.930 present and discuss certain forward looking statements concerning 00:00:41.930 -- 00:00:45.735 future transactions, the development of Vivoryon's core platform, 00:00:45.895 -- 00:00:48.935 the progress of its research and development programs, 00:00:49.015 -- 00:00:51.335 and the initiation of additional programs, 00:00:51.495 -- 00:00:53.975 as well as results of operations, cash needs, 00:00:53.975 -- 00:00:55.335 financial conditions, 00:00:55.815 -- 00:00:57.735 liquidity prospects, and strategies. 00:00:59.220 -- 00:01:02.180 Should actual results differ from the company's assumpt...